TY - JOUR
T1 - Patterns of remission and relapse in obsessive-compulsive disorder
T2 - A 2- year prospective study
AU - Eisen, Jane L.
AU - Goodman, Wayne K.
AU - Keller, Martin B.
AU - Warshaw, Meredith G.
AU - DeMarco, Lynne M.
AU - Luce, Douglas D.
AU - Rasmussen, Steven A.
PY - 1999/5
Y1 - 1999/5
N2 - Objective: This study examined the course of illness in patients with obsessive-compulsive disorder (OCD) over a 2-year period. Method: Sixty-six patients with a primary diagnosis of DSM-III-R OCD were followed prospectively for 2 years. Baseline information was collected on demographic characteristics, Axis I and II diagnoses, and severity of OCD symptoms. Follow-up measures obtained at 3, 6, 12, and 24 months after baseline assessment included information on symptomatic and diagnostic status as well as behavioral and somatic treatments received. Results: The probability of full remission from OCD over the 2-year period was 12%. The probability of partial remission was 47%. After achieving remission from OCD, the probability of relapse was 48%. No factors were identified that significantly predicted full or partial remission. Seventy-seven percent (N = 51) of the subjects received a serotonin reuptake inhibitor (SRI) for ≥ 12 weeks, and 68% (N = 45) received medium-to-high doses of SRIs for ≥ 12 weeks. Only 18% received a full trial of behavior therapy. Conclusion: Despite exposure to at least 1 adequate trial of an SRI, the likelihood of full remission of OCD in this study was low. Results of this study also suggest that behavior therapy may be underutilized.
AB - Objective: This study examined the course of illness in patients with obsessive-compulsive disorder (OCD) over a 2-year period. Method: Sixty-six patients with a primary diagnosis of DSM-III-R OCD were followed prospectively for 2 years. Baseline information was collected on demographic characteristics, Axis I and II diagnoses, and severity of OCD symptoms. Follow-up measures obtained at 3, 6, 12, and 24 months after baseline assessment included information on symptomatic and diagnostic status as well as behavioral and somatic treatments received. Results: The probability of full remission from OCD over the 2-year period was 12%. The probability of partial remission was 47%. After achieving remission from OCD, the probability of relapse was 48%. No factors were identified that significantly predicted full or partial remission. Seventy-seven percent (N = 51) of the subjects received a serotonin reuptake inhibitor (SRI) for ≥ 12 weeks, and 68% (N = 45) received medium-to-high doses of SRIs for ≥ 12 weeks. Only 18% received a full trial of behavior therapy. Conclusion: Despite exposure to at least 1 adequate trial of an SRI, the likelihood of full remission of OCD in this study was low. Results of this study also suggest that behavior therapy may be underutilized.
UR - http://www.scopus.com/inward/record.url?scp=0033039954&partnerID=8YFLogxK
U2 - 10.4088/JCP.v60n0514
DO - 10.4088/JCP.v60n0514
M3 - Article
C2 - 10362449
AN - SCOPUS:0033039954
SN - 0160-6689
VL - 60
SP - 346
EP - 351
JO - Journal of Clinical Psychiatry
JF - Journal of Clinical Psychiatry
IS - 5
ER -